OncoZenge AB (publ) (OM:ONCOZ) Explores Strategic Options for Bupizenge? in China. To Explore Strategic Options for Introduction of Bupizenge in China.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.955 SEK | +2.20% | +2.99% | +27.99% |
04-08 | Oncozenge AB Appoints Paolo Bossi as Member of the Advisory Board | CI |
04-04 | OncoZenge Announces Read-Out of Positive Stability Data for BupiZenge | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.99% | 4.27M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- ONCOZ Stock
- News OncoZenge AB
- Oncozenge Explores Strategic Options for Bupizeng in China